Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AxoGen, Inc. (NASDAQ: AXGN) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $30.00 price target on the stock.
AxoGen, Inc. (NASDAQ: AXGN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $24.00 price target on the stock.
AxoGen, Inc. (NASDAQ: AXGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $22.00 to $26.00. They now have a "buy" rating on the stock.